Somahlution
Manufacturing · Florida, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
225 Chimney Corner Ln Ste 2001, Jupiter,...Phone Number
(561) 935-9955Website
www.somahlution.comRevenue
<$5 MillionIndustry
About Somahlution
Marizyme Inc is a biotechnology company focused on innovative healthcare solutions and medical advancements. They offer DuraGraft Technology, the first FDA-cleared solution for the flushing and storage of saphenous vein grafts during Coronary Artery Bypass Grafting (CABG). This technology aims to reduce oxidative damage and maintain cell viability, demonstrating improved outcomes for grafts compared to traditional saline storage. Their intended clients include healthcare providers and institutions involved in cardiac surgery.Explore more
Somahlution Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Somahlution
Compare insights from companies similar to Somahlution, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Somahlution Tech Stack
A closer look at the technologies used by Somahlution
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Somahlution
Sign Up For FreeTo access detailed company insights
Marizyme Inc is a biotechnology company focused on innovative healthcare solutions and medical advancements. They offer DuraGraft Technology, the first FDA-cleared solution for the flushing and storage of saphenous vein grafts during Coronary Artery Bypass Grafting (CABG). This technology aims to reduce oxidative damage and maintain cell viability,... Read More
